How to pick the next small-cap takeover target
M&A activity is hotting up across the board, with undervalued small to mid-caps stocks offering the best value.
Stockhead
Pay attention to ASX copper sleeper
ASX copper hopeful KGL Resources continues to fly under the radar, but Barry FitzGerald sees plenty of reasons to take a look.
Which ASX medtech soared 70pc this week?
Micro-X’s 70% climb this week proves momentum is returning to the ASX healthcare sector, notes Morgans analyst Scott Power.
Race submits key ethics application for cancer trial
Race Oncology has submitted a human ethics regulatory package for its phase I trial in solid tumour patients using the RC220 bisantrene drug.
More Stories
Everything you need to know before the ASX opens
Here’s everything you need to know before the ASX opens today.
Closing Bell: Iron ore lifts ASX record
The ASX hit a record high on Thursday, driven by mining stocks, while the unemployment rate remained tight at 4.2%.
GreenTech proves it’s no one-hit Whundo
Copper hits from GreenTech have the explorer on the up and up, while WA gas stocks have rare good government news.
GTR goes deep for uranium at Lo Herma
GTI Energy’s intersection of deeper uranium mineralisation could boost resources at its Lo Herma ISR project in Wyoming.
ASX recovers well from Fed hangover
The ASX reached a new record high this morning following the first rate cut from the US Fed in more than four years. It has since fallen back again, but the day is still young-ish yet…
SMS eyes 51pc stake in Namibian uranium project
Star Minerals enters farm-in and JV with Madison Metals to acquire up to 51pc of the Cobra uranium project in Namibia.
Wall Street dips as Powell tones down optimism
Jerome Powell clarified the 50 basis point rate cut doesn’t signal a major shift in policy, causing Wall Street to reverse early gains.
Javelin drilling to deliver resource growth
Javelin Minerals’ planned exploration drilling will seek to extend known mineralisation along strike from and below the main Coogee pit.
Pot play Cann Group eyes earnings turnaround
After heavy losses, medical cannabis pioneer Cann Group expects to return to underlying profitability this year.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Friday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/193